Literature DB >> 21953456

Mechanism of HIV reverse transcriptase inhibition by zinc: formation of a highly stable enzyme-(primer-template) complex with profoundly diminished catalytic activity.

Katherine J Fenstermacher1, Jeffrey J DeStefano.   

Abstract

Several physiologically relevant cations including Ca(2+), Mn(2+), and Zn(2+) have been shown to inhibit HIV reverse transcriptase (RT), presumably by competitively displacing one or more Mg(2+) ions bound to RT. We analyzed the effects of Zn(2+) on reverse transcription and compared them to Ca(2+) and Mn(2+). Using nucleotide extension efficiency as a readout, Zn(2+) showed significant inhibition of reactions with 2 mM Mg(2+), even when present at only ∼5 μM. Mn(2+) and Ca(2+) were also inhibitory but at higher concentrations. Both Mn(2+) and Zn(2+) (but not Ca(2+)) supported RT incorporation in the absence of Mg(2+) with Mn(2+) being much more efficient. The maximum extension rates with Zn(2+), Mn(2+), and Mg(2+) were ∼0.1, 1, and 3.5 nucleotides per second, respectively. Zinc supported optimal RNase H activity at ∼25 μM, similar to the optimal for nucleotide addition in the presence of low dNTP concentrations. Surprisingly, processivity (average number of nucleotides incorporated in a single binding event with enzyme) during reverse transcription was comparable with Zn(2+) and Mg(2+), and single RT molecules were able to continue extension in the presence of Zn(2+) for several hours on the same template. Consistent with this result, the half-life for RT-Zn(2+)-(primer-template) complexes was 220 ± 60 min and only 1.7 ± 1 min with Mg(2+), indicating ∼130-fold more stable binding with Zn(2+). Essentially, the presence of Zn(2+) promotes the formation of a highly stable slowly progressing RT-(primer-template) complex.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21953456      PMCID: PMC3220506          DOI: 10.1074/jbc.M111.289850

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  45 in total

1.  Parameters that influence processive synthesis and site-specific termination by human immunodeficiency virus reverse transcriptase on RNA and DNA templates.

Authors:  J J DeStefano; R G Buiser; L M Mallaber; P J Fay; R A Bambara
Journal:  Biochim Biophys Acta       Date:  1992-07-15

Review 2.  Zinc proteins: enzymes, storage proteins, transcription factors, and replication proteins.

Authors:  J E Coleman
Journal:  Annu Rev Biochem       Date:  1992       Impact factor: 23.643

Review 3.  Retroviral reverse transcriptase: synthesis, structure, and function.

Authors:  S P Goff
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1990

4.  Functional characterization of RNA-dependent DNA polymerase and RNase H activities of a recombinant HIV reverse transcriptase.

Authors:  C K Tan; J Zhang; Z Y Li; W G Tarpley; K M Downey; A G So
Journal:  Biochemistry       Date:  1991-03-12       Impact factor: 3.162

5.  Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone.

Authors:  A Adachi; H E Gendelman; S Koenig; T Folks; R Willey; A Rabson; M A Martin
Journal:  J Virol       Date:  1986-08       Impact factor: 5.103

Review 6.  The biochemical basis of zinc physiology.

Authors:  B L Vallee; K H Falchuk
Journal:  Physiol Rev       Date:  1993-01       Impact factor: 37.312

7.  T7 DNA polymerase is not a zinc-metalloenzyme and the polymerase and exonuclease activities are inhibited by zinc ions.

Authors:  I Slaby; B Lind; A Holmgren
Journal:  Biochem Biophys Res Commun       Date:  1984-08-16       Impact factor: 3.575

8.  Metal binding to DNA polymerase I, its large fragment, and two 3',5'-exonuclease mutants of the large fragment.

Authors:  G P Mullen; E H Serpersu; L J Ferrin; L A Loeb; A S Mildvan
Journal:  J Biol Chem       Date:  1990-08-25       Impact factor: 5.157

9.  Polymerization and RNase H activities of the reverse transcriptases from avian myeloblastosis, human immunodeficiency, and Moloney murine leukemia viruses are functionally uncoupled.

Authors:  J J DeStefano; R G Buiser; L M Mallaber; T W Myers; R A Bambara; P J Fay
Journal:  J Biol Chem       Date:  1991-04-25       Impact factor: 5.157

Review 10.  Physiological concentrations of purines and pyrimidines.

Authors:  T W Traut
Journal:  Mol Cell Biochem       Date:  1994-11-09       Impact factor: 3.396

View more
  21 in total

1.  A single dose of a MIV-150/Zinc acetate gel provides 24 h of protection against vaginal simian human immunodeficiency virus reverse transcriptase infection, with more limited protection rectally 8-24 h after gel use.

Authors:  Jessica Kenney; Rachel Singer; Nina Derby; Meropi Aravantinou; Ciby J Abraham; Radhika Menon; Samantha Seidor; Shimin Zhang; Agegnehu Gettie; James Blanchard; Michael Piatak; Jeffrey D Lifson; José A Fernández-Romero; Thomas M Zydowsky; Melissa Robbiani
Journal:  AIDS Res Hum Retroviruses       Date:  2012-07-30       Impact factor: 2.205

2.  Binding thermodynamics of metal ions to HIV-1 ribonuclease H domain.

Authors:  Masayuki Oda; Zhaoyong Xi; Satomi Inaba; Ryan L Slack; Rieko Ishima
Journal:  J Therm Anal Calorim       Date:  2018-06-09       Impact factor: 4.626

3.  Determinants of Active-Site Inhibitor Interaction with HIV-1 RNase H.

Authors:  Zhaoyong Xi; Zhengqiang Wang; Stefan G Sarafianos; Nataliya S Myshakina; Rieko Ishima
Journal:  ACS Infect Dis       Date:  2019-10-02       Impact factor: 5.084

4.  A modified zinc acetate gel, a potential nonantiretroviral microbicide, is safe and effective against simian-human immunodeficiency virus and herpes simplex virus 2 infection in vivo.

Authors:  Jessica Kenney; Aixa Rodríguez; Larisa Kizima; Samantha Seidor; Radhika Menon; Ninochka Jean-Pierre; Pavel Pugach; Keith Levendosky; Nina Derby; Agegnehu Gettie; James Blanchard; Michael Piatak; Jeffrey D Lifson; Gabriela Paglini; Thomas M Zydowsky; Melissa Robbiani; José A Fernández Romero
Journal:  Antimicrob Agents Chemother       Date:  2013-06-10       Impact factor: 5.191

5.  Inhibition of aminoglycoside 6'-N-acetyltransferase type Ib by zinc: reversal of amikacin resistance in Acinetobacter baumannii and Escherichia coli by a zinc ionophore.

Authors:  David L Lin; Tung Tran; Jamal Y Alam; Steven R Herron; Maria Soledad Ramirez; Marcelo E Tolmasky
Journal:  Antimicrob Agents Chemother       Date:  2014-05-12       Impact factor: 5.191

6.  Additive Effects of Zinc Chloride on the Suppression of Hepatitis A Virus Replication by Interferon in Human Hepatoma Huh7 Cells.

Authors:  Tatsuo Kanda; Reina Sasaki; Ryota Masuzaki; Hiroshi Takahashi; Mariko Fujisawa; Naoki Matsumoto; Hiroaki Okamoto; Mitsuhiko Moriyama
Journal:  In Vivo       Date:  2020 Nov-Dec       Impact factor: 2.155

7.  Human immunodeficiency virus reverse transcriptase displays dramatically higher fidelity under physiological magnesium conditions in vitro.

Authors:  Vasudevan Achuthan; Brian J Keith; Bernard A Connolly; Jeffrey J DeStefano
Journal:  J Virol       Date:  2014-05-21       Impact factor: 5.103

8.  MIV-150 and zinc acetate combination provides potent and broad activity against HIV-1.

Authors:  Olga Mizenina; Mayla Hsu; Ninochka Jean-Pierre; Meropi Aravantinou; Keith Levendosky; Gabriela Paglini; Thomas M Zydowsky; Melissa Robbiani; José A Fernández-Romero
Journal:  Drug Deliv Transl Res       Date:  2017-12       Impact factor: 5.671

Review 9.  Aristocratic human papillomavirus drove cervical cancer: a study of the therapeutic potential of the combination of interferon with zinc.

Authors:  Yun-He Gao; Lei Yu; Zhong-Shan Liu; Yun-Feng Li
Journal:  Mol Cell Biochem       Date:  2020-10-24       Impact factor: 3.396

10.  Metal and ligand binding to the HIV-RNase H active site are remotely monitored by Ile556.

Authors:  Xunhai Zheng; Geoffrey A Mueller; Eugene F DeRose; Robert E London
Journal:  Nucleic Acids Res       Date:  2012-08-31       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.